![Sun Altbach](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sun Altbach
Directeur/Membre du Conseil chez Termeer Foundation
Profil
Sun Altbach is a Senior Scientific Advisor at Longevity Vision Fund and an Advisory Board Member at Termeer Foundation.
Previously, she was the President, Chief Executive Officer & Director at PIC Therapeutics, Inc., Senior Director at OvaScience, Inc., and Vice President at Finch Research & Development LLC.
Ms. Altbach received her undergraduate degree from Smith College and her MBA from MIT Sloan School of Management.
Postes actifs de Sun Altbach
Sociétés | Poste | Début |
---|---|---|
Longevity Vision Fund
![]() Longevity Vision Fund Investment ManagersFinance Longevity Vision Fund (Longevity Vision Fund) is a venture capital firm founded in 2018 by Sergey Young. The firm is headquartered in New York. | Consultant / Advisor | 01/10/2021 |
Termeer Foundation | Directeur/Membre du Conseil | 01/01/2020 |
Anciens postes connus de Sun Altbach
Sociétés | Poste | Fin |
---|---|---|
PIC Therapeutics, Inc.
![]() PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Directeur Général | 01/01/2020 |
Finch Research & Development LLC
![]() Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | Private Equity Investor | 01/01/2018 |
OvaScience, Inc.
![]() OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Directeur/Membre du Conseil | 01/01/2017 |
Formation de Sun Altbach
Smith College | Undergraduate Degree |
MIT Sloan School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 5 |
---|---|
OvaScience, Inc.
![]() OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
Finch Research & Development LLC
![]() Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | Health Technology |
Longevity Vision Fund
![]() Longevity Vision Fund Investment ManagersFinance Longevity Vision Fund (Longevity Vision Fund) is a venture capital firm founded in 2018 by Sergey Young. The firm is headquartered in New York. | Finance |
PIC Therapeutics, Inc.
![]() PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Health Technology |
Termeer Foundation |